Neurotech International Limited (NTI.AX)
- Previous Close
0.0900 - Open
0.0890 - Bid 0.0890 x 100
- Ask 0.0900 x 5680400
- Day's Range
0.0870 - 0.0900 - 52 Week Range
0.0310 - 0.1250 - Volume
1,439,697 - Avg. Volume
2,303,146 - Market Cap (intraday)
82.565M - Beta (5Y Monthly) 1.79
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date Feb 27, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Neurotech International Limited, together with its subsidiaries, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. The company is focused on development and commercializing Mente platform, a platform technology to monitor and play role in home-based therapies. Its products includes Mente Autism for the diagnosis and treatment of autism. It also engages in executing of medical research projects; and developing of technological devices. Neurotech International Limited was incorporated in 2016 and is based in Nedlands, Australia.
www.neurotechinternational.comRecent News: NTI.AX
Performance Overview: NTI.AX
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NTI.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NTI.AX
Valuation Measures
Market Cap
82.56M
Enterprise Value
78.09M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
17.46k
Price/Book (mrq)
17.22
Enterprise Value/Revenue
17.44k
Enterprise Value/EBITDA
-9.47
Financial Highlights
Profitability and Income Statement
Profit Margin
-155.47%
Return on Assets (ttm)
-45.05%
Return on Equity (ttm)
-74.66%
Revenue (ttm)
3.2M
Net Income Avi to Common (ttm)
-4.98M
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
4.48M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-2.8M
Company Insights: NTI.AX
NTI.AX does not have Company Insights